Journal: PLoS ONE
Article Title: Rho-ROCK and Rac-PAK Signaling Pathways Have Opposing Effects on the Cell-to-Cell Spread of Marek's Disease Virus
doi: 10.1371/journal.pone.0044072
Figure Lengend Snippet: (A) Effect of TAT-C3 transferase, an inhibitor of Rho proteins. Upper panel, F-actin staining of non-infected CESCs treated with 16 µg/mL of TAT-C3 transferase (bar, 20 µm). Lower panel, a picture of a representative BAC20-EGFP infection plaque obtained with 16 µg/mL of TAT-C3 transferase (bar, 200 µm). Right panel, the graph shows a quantitative analysis of plaques size in one of two to three representative experiments (***, p<0.001). The error bars represent the SEM of 50 plaques size. (B) Effect of LPA, an activator of Rho proteins, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (***, p<0.001). (C) Effect of Y-27632, an inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques sizes (right panel), as in A (***, p<0.001). (D) Effect of Fasudil, a second inhibitor of ROCKs, on F-actin (upper panel), plaques shape (lower panel) and plaques size (right panel), as in A (*, 0.1
Article Snippet: Stock solutions were made in dimethyl sulfoxide (DMSO) for: cytochalasin D (CytD) (C8273, Sigma) at 20 mM, jasplakinolide (Jaspl) (J7473, Invitrogen) at 1 mM, IPA-3 (cat#506106, Calbiochem) at 20 mM, blebbistatin (Bleb) (B0560, Sigma) at 25 mM.
Techniques: Staining, Infection, Western Blot, Labeling, Activity Assay, Concentration Assay